Deciphering the Pharmacological Potential of Kouqiangjie Formula for the Treatment of Diabetic Periodontitis Based on Network Pharmacology, Machine Learning, Molecular Dynamics, and Animal Experiments
Drug Design, Development and Therapy · 2025-03 · Volume 19 · 2103-2129
DOI: 10.2147/dddt.s494066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-03. Verfasst von Yeke Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, People's Republic of China. Hauptthemen laut MEDLINE: Network Pharmacology, Periodontitis, Diabetes Mellitus, Type 2, Machine Learning. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Periodontitis (PD) and type 2 diabetes mellitus (T2DM) represent interlinked global health burdens, commonly causing significant clinical complications when coincident. Therefore, managing both conditions (T2DM with periodontitis, DP) simultaneously poses considerable challenges, necessitating novel therapeutic strategies. KQJF has been clinically proven to treat DP with good efficacy, but its pharmacological substances and targets are not clear and urgently need to be clarified.
Aim
To define the potential active components and targets of KQJF for the treatment of DP. Materials and Methods: The investigation commenced with the application of UPLC-Q-TOF/MS analysis to delineate the active constituents of KQJF and their associated targets in addressing DP. Additionally, the research incorporated subsequent methodologies such as machine learning, network pharmacology, molecular docking, molecular dynamics simulations, and a DP rat model was established and validated by in vivo experiments using H&E staining, immunohistochemistry, quantitative real-time PCR, and Western blot.
Results
KQJF was found to contain 49 prototype compounds and 121 metabolites with potential activity against PD and T2DM. Network pharmacology revealed 66 overlapping genes between the pharmacological targets of KQJF and known targets of PD and T2DM. Further exploration through PPI network and enrichment analyses illuminated the involvement of multi-target and multi-pathway mechanisms. Molecular docking and dynamics simulations confirmed the robust interactions between key compounds within KQJF and proteins associated with the diseases. In vivo validation demonstrated that KQJF treatment ameliorated DP-associated histopathological changes and modulated the expression of crucial proteins (including ABCG2, CCND1, CDKN1B, HIF1A, and PIK3R1) in a DP rat model.
Conclusion
In summary, KQJF exhibits potential therapeutic benefits for DP through a multi-component and multi-target approach, potentially offering a novel integrative treatment strategy. This study underscores the importance of integrating traditional medicine with modern molecular techniques to explore novel therapeutic avenues for complex comorbid conditions, providing a blueprint for future pharmacological explorations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, People's Republic of China.
- School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, People's Republic of China.
- Department of Gynaecology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, People's Republic of China.
- Department of Gynaecology, Henan Provincial People's Hospital, Zhengzhou, 450000, People's Republic of China.
- College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, People's Republic of China.
- Department of Nuclear Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610072, People's Republic of China.
ORCID-Profile: Yeke Wu
Zitieren
APA
Wu, Y., Li, J., Liu, M., Gao, R., Li, H., Xie, Y., Hu, Q., Wei, J., Zhao, L., & Li, L. (2025). Deciphering the Pharmacological Potential of Kouqiangjie Formula for the Treatment of Diabetic Periodontitis Based on Network Pharmacology, Machine Learning, Molecular Dynamics, and Animal Experiments. Drug Design, Development and Therapy, Volume 19, 2103-2129. https://doi.org/10.2147/dddt.s494066
Vancouver
Wu Y, Li J, Liu M, Gao R, Li H, Xie Y, et al. Deciphering the Pharmacological Potential of Kouqiangjie Formula for the Treatment of Diabetic Periodontitis Based on Network Pharmacology, Machine Learning, Molecular Dynamics, and Animal Experiments. Drug Design, Development and Therapy. 2025;Volume 19:2103-2129. doi:10.2147/dddt.s494066
BibTeX
@article{Wu2025,
author = {Wu, Yeke and Li, Jiawei and Liu, Min and Gao, Ranran and Li, Huijing and Xie, Yunfei and Hu, Qiongying and Wei, Jing and Zhao, Lixing and Li, Li},
title = {Deciphering the Pharmacological Potential of Kouqiangjie Formula for the Treatment of Diabetic Periodontitis Based on Network Pharmacology, Machine Learning, Molecular Dynamics, and Animal Experiments},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {2103--2129},
doi = {10.2147/dddt.s494066}
}
EUVIMED